A Breakthrough Global Study of Depression Finds 44 Genetic Variants Linked to the Disease

iStock
iStock

Though depression affects an estimated 14 percent of the world’s population, scientists know very little about the underlying causes of the disorder, and that makes it incredibly difficult to treat. Even now, researchers are still debating whether common antidepressant medications even work at all, and if they do, why.

New research published in the journal Nature Genetics provides a big step in figuring out why some people suffer from depression while others don’t, identifying 44 genetic variants that are risk factors for major depression, 30 of which are new. They also found two regions of the brain that appear to be associated with the development of the disorder.

The study is the result of an international effort by more than 200 researchers involved with the Psychiatric Genomics Consortium. It looked at more than 135,000 cases of depression (both self-reported and clinically assessed) and almost 345,000 control cases. It’s the largest study on the genetic basis of depression ever done.

The researchers found that all humans carry some of the 44 risk factors identified. Some people carry more than others, putting them at greater risk for developing depression. They also identified the prefrontal and anterior cingulate cortices (both located at the front of the brain) as the regions of the brain probably linked with the development of depression.

Some of the risk factors the researchers identified are also involved in other psychiatric disorders, like schizophrenia, which isn't entirely surprising—a 2007 study from the Psychiatric Genomics Consortium found that people with depression, bipolar disorder, and schizophrenia as well as developmental disorders like ADHD and autism share the same variations in four locations in their genetic code.

By identifying genetic risk factors associated with major depressive disorder, the scientists hope to increase our understanding of why depression strikes some people and not others. "[M]ajor depression is a brain disorder," the researchers conclude. "Although this is not unexpected, some past models of [major depressive disorder] have had little or no place for heredity or biology." They firmly put to rest the idea that depression is entirely a matter of environment.

Environment certainly plays a role—the researchers found links between lower education levels and higher body mass index and depression risk as well—but genetics may impact whether someone whose circumstances put them at risk of depression actually develops the disorder. Depression is still highly stigmatized, which often prevents people from seeking treatment for it, according to several studies. Further understanding of the genetic underpinnings of the disorder may help counter negative perceptions of depression as a character flaw or a sign of laziness.

The study could eventually change how doctors treat depression. Many of the genetic variants identified by this study are linked to targets of current antidepressant medications, like serotonin. But the research may also lead to the development of new medications and therapies that could work for more people (current medications don't work for everyone) and potentially have fewer side effects than existing treatments.

The study partially relied on self-reported depression diagnoses, meaning there's some wiggle room in knowing whether those people are actually clinically depressed to the degree that a medical professional would diagnose. Further research will need to confirm that these genetic variants are indeed linked to depression. There are likely even more gene variants related to depression risk, as well, but they might have too small of an effect to be identified by this study. The researchers hope to continue their work to understand the links between environmental stressors, genetic variations, and depression risk in the future.

Pioneering Heart Surgeon René Favaloro Is Being Honored With a Google Doodle

Dr. René Favaloro (left) pictured with colleague Dr. Mason Sones.
Dr. René Favaloro (left) pictured with colleague Dr. Mason Sones.
The Cleveland Clinic Center for Medical Art & Photography, Wikimedia Commons // CC BY 4.0

Argentinian heart surgeon René Favaloro is the subject of today’s Google Doodle, which features a sketched portrait of the doctor along with an anatomical heart and several medical tools, The Independent reports.

The renowned doctor was born on this day in 1923 in La Plata, the capital of Argentina’s Buenos Aires province, and pursued a degree in medicine at La Plata University. After 12 years as a doctor in La Pampa, where he established the area’s first mobile blood bank, trained nurses, and built his own operating room, Favaloro relocated to the U.S. to specialize in thoracic surgery at the Cleveland Clinic.

In 1967, Favaloro performed coronary bypass surgery on a 51-year-old woman whose right coronary artery was blocked, restricting blood flow to her heart. Coronary bypass surgery involves taking a healthy vein from elsewhere in the body (in this case, Favaloro borrowed from the patient’s leg, but you can also use a vein from the arm or chest), and using it to channel the blood from the artery to the heart, bypassing the blockage. According to the Mayo Clinic, it doesn’t cure whatever heart disease that caused the blocked artery, but it can relieve symptoms like chest pain and shortness of breath, and it gives patients time to make other lifestyle changes to further manage their disease.

Favaloro wasn’t keen on being called the “father” of coronary bypass surgery, but his work brought the procedure to the forefront of the clinical field. He moved back to Argentina in 1971 and launched the Favaloro Foundation to train surgeons and treat a variety of patients from diverse economic backgrounds.

Favaloro died by suicide on July 29, 2000, at the age of 77, by a gunshot wound to the chest. His wife had died several years prior, and his foundation had fallen deeply into debt, which Argentinian hospitals and medical centers declined to help pay, The New York Times reported at the time.

“As a surgeon, Dr. Favaloro will be remembered for his ingenuity and imagination,” his colleague Dr. Denton A. Cooley wrote in a tribute shortly after Favaloro’s death. “But as a man ... he will be remembered for his compassion and selflessness.” Today would have been his 96th birthday.

[h/t The Independent]

Forget Lab-Grown Meat—You Can Now Buy Lab-Grown Ice Cream

Deagreez/iStock via Getty Images
Deagreez/iStock via Getty Images

Even though “dairy-free” doesn’t necessarily mean “healthier,” it’s still a necessary disclaimer for dairy-free people who are screaming for ice cream. And between veganism, lactose intolerance, and other dietary dairy restrictions, the race is on to create an ice cream for the masses that doesn’t taste like chalk, chemicals, or sadness.

Bay Area startup Perfect Day may have just pulled ahead of the competition. Today, Fast Company reports, it released three flavors of dairy-free ice cream—Vanilla Salted Fudge, Milky Chocolate, and Vanilla Blackberry Toffee—that contain the same proteins found in cow dairy, but grown in a lab from engineered yeast and DNA. Since those proteins contribute greatly to the rich texture and taste of ice cream that we love so much, Perfect Day’s products are supposedly indistinguishable from the real thing.


View this post on Instagram

A post shared by Perfect Day (@perfectdayfoods) on

The co-founders, vegan bioengineers Ryan Pandya and Perumal Gandhi, got the idea from their experience in medicine, where fermentation is used to grow things in a lab all the time. “The two of us started scratching our heads and wondering, what if we just apply that same exact technology that’s been around for half a century to make the world’s most in-demand, highest-quality protein?” Pandya explained to Fast Company.

Their lactose-, dairy-, and gluten-free vegan ice cream, which they’ve been working on for five years, includes the dairy proteins casein and whey, as well as plant-based fats and sugar. If you're dairy-free because of a casein or whey allergy or sensitivity, you should treat this ice cream like you would any other foods containing dairy, and heed the "Contains milk protein" disclaimer on Perfect Day products.

Lab-grown dairy has environmental benefits too, considering that cows and other livestock are major culprits of greenhouse gas emissions. Pandya and Gandhi hope to sell their proteins to large-scale food manufacturers, and have teamed up with Archer Daniels Midland, an Illinois-based food processing company, to increase production.

Though it seems like a scoop or two of this ice cream might be the recipe for a perfect day, that wasn’t the inspiration behind the company’s name—the founders stumbled upon a study in which scientists discovered that cows produced more milk when listening to music, and one of the most successful songs was Lou Reed’s “Perfect Day.” “As a company on a mission to make cows, people, and the planet happier, it seemed like a perfect fit,” the website says.

Can’t wait to taste the magic? You can purchase all three flavors in a three-pint bundle for $60 here.

[h/t Fast Company]

SECTIONS

arrow
LIVE SMARTER